Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION AND WARRANTS (Tables)

v3.23.2
SHARE-BASED COMPENSATION AND WARRANTS (Tables)
12 Months Ended
Jun. 30, 2023
SHARE-BASED COMPENSATION AND WARRANTS  
Schedule of the number of shares authorized, outstanding, and available for future grants under stock option

Presented below is a summary of the number of shares authorized, outstanding, and available for future grants under each of the Company’s stock option plans as of June 30, 2023 (in thousands):

    

Plan Termination

    

Number of Shares

Description

    

Date

    

Authorized

    

Outstanding

    

Available

2015 Plan

 

February 2020

 

17

 

17

 

2016 Plan

 

October 2021

 

140

 

140

 

2019 Plan

 

July 2029

 

200

 

200

 

2021 Plan

March 2031

10,700

8,388

2,312

Total

 

  

 

11,057

 

8,745

 

2,312

Summary of the stock option plans

The following table sets forth a summary of the combined activity under all of the Company’s stock option plans for the fiscal years ended June 30, 2023 and 2022 (shares in thousands):

2023

2022

    

Shares

    

Price (1)

    

Term (2)

    

Shares

    

Price (1)

    

Term (2)

Outstanding, beginning of fiscal year

 

8,506

$

5.24

9.7

 

1,285

$

16.35

 

8.7

Grants to employees

740

2.00

7,373

3.51

Expired

(116)

40.73

(78)

19.03

Forfeited

(385)

3.75

(74)

9.72

Outstanding, end of fiscal year

 

8,745

 

4.56

 

8.8

 

8,506

 

5.24

 

9.7

Vested, end of fiscal year

 

2,676

 

6.57

 

8.4

 

685

 

18.63

 

7.5

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term until the stock options expire.
Schedule of the fair value of stock options The fair value of stock options was estimated on the dates of grant using the BSM option-pricing model, with the following weighted-average assumptions for the fiscal years ended June 30, 2023 and 2022:

    

2023

2022

Market price of common stock on grant date

$

3.73

$

3.51

Expected volatility

    

91

%

94

%

Risk free interest rate

 

3.7

%

3.1

%

Expected term (years)

 

6.0

6.1

Dividend yield

 

0

%

0

%

Schedule of share-based compensation expense

Share-based compensation expense is included under the following captions in the consolidated statements of operations for the fiscal years ended June 30, 2023 and 2022 (in thousands):

2023

    

2022

Research and development

$

3,243

$

1,405

General and administrative

 

4,025

 

2,280

Total

$

7,268

$

3,685

Schedule of warrant activity Excluding the pre-funded warrants discussed above, the following table summarizes activity for all other warrants for the fiscal years ended June 30, 2023 and 2022 (shares in thousands):

2023

2022

    

Shares

    

Price (1)

    

Term (2)

    

Shares

    

Price (1)

    

Term (2)

Outstanding, beginning of fiscal year

 

1,150

  

$

22.83

 

4.2

 

1,252

  

$

28.91

 

4.8

Expirations

 

(262)

  

 

25.32

 

  

 

(102)

  

 

97.79

 

  

Outstanding, end of fiscal year

 

888

  

 

22.10

 

3.5

 

1,150

  

 

22.83

 

4.2

(1) Represents the weighted average exercise price.
(2) Represents the weighted average remaining contractual term for the number of years until the warrants expire.